InterventionsReview

Tirzepatide and the Incidence of Atrial Fibrillation in Adults With Overweight or Obesity: An Updated Meta-Analysis of Randomized Controlled Trials

Journal of the American Heart Association

The paper

Ensieh Sadat Mansouri, Flávia Queiroga, Lucas Barbosa,

A K Azevedo, Webster Donaldy, M J Mirbolouk, Camila Verônica Souza Freire, André Rivera, Iuri Ferreira Félix, Marconi Abreu, Abhishek J. Deshmukh,

Christopher V. DeSimone

Tehran University of Medical Sciences · Mayo Clinic

Journal of the American Heart Association · 9 Sep 2026

doi.org/10.1161/jaha.125.044249 PubMed 42714458

A triple-target drug cut body weight by up to 19.7% in a trial
Cell Metabolism · 8 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026